[HTML][HTML] Interleukin-6 (IL-6) inhibitors as therapeutic agents for coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis
RT Pinzon, VO Wijaya, RB Buana - Journal of infection and public health, 2021 - Elsevier
Introduction Preliminary studies showed that coronavirus disease 2019 (COVID-19) disrupts
body immune system, including dysregulation of cytokine interleukin-6 (IL-6). IL-6 inhibitors …
body immune system, including dysregulation of cytokine interleukin-6 (IL-6). IL-6 inhibitors …
[PDF][PDF] Interleukin-6 (IL-6) inhibitors as therapeutic agents for coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis
RT Pinzon, VO Wijaya, RB Buana - Journal of Infection and Public …, 2021 - researchgate.net
abstract Introduction: Preliminary studies showed that coronavirus disease 2019 (COVID-19)
disrupts body immune system, including dysregulation of cytokine interleukin-6 (IL-6). IL-6 …
disrupts body immune system, including dysregulation of cytokine interleukin-6 (IL-6). IL-6 …
[HTML][HTML] Interleukin-6 (IL-6) inhibitors as therapeutic agents for coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis
RT Pinzon, VO Wijaya, RB Buana - Journal of Infection and Public …, 2021 - ncbi.nlm.nih.gov
Objective We performed a systematic review and meta-analysis to synthesize the available
evidence on the potential therapeutic effect of IL-6 inhibitor agents for the treatment of …
evidence on the potential therapeutic effect of IL-6 inhibitor agents for the treatment of …
Interleukin-6 (IL-6) inhibitors as therapeutic agents for coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis
RT Pinzon, VO Wijaya… - Journal of infection and …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction Preliminary studies showed that coronavirus disease 2019 (COVID-19) disrupts
body immune system, including dysregulation of cytokine interleukin-6 (IL-6). IL-6 inhibitors …
body immune system, including dysregulation of cytokine interleukin-6 (IL-6). IL-6 inhibitors …
Interleukin-6 (IL-6) inhibitors as therapeutic agents for coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
RT Pinzon, VO Wijaya, RB Buana - Journal of Infection and Public …, 2021 - europepmc.org
Objective We performed a systematic review and meta-analysis to synthesize the available
evidence on the potential therapeutic effect of IL-6 inhibitor agents for the treatment of …
evidence on the potential therapeutic effect of IL-6 inhibitor agents for the treatment of …
Interleukin-6 (il-6) inhibitors as therapeutic agents for coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis.
RT Pinzon, VO Wijaya, RB Buana - 2021 - cabidigitallibrary.org
Introduction: Preliminary studies showed that coronavirus disease 2019 (COVID-19) disrupts
body immune system, including dysregulation of cytokine interleukin-6 (IL-6). IL-6 inhibitors …
body immune system, including dysregulation of cytokine interleukin-6 (IL-6). IL-6 inhibitors …